LASN-01

N/A

Report date: 2025/04/02 10:22:06
First In Class

Base Information

Drug NameLASN-01
Drug Alias NameLASN-01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionInterleukin 11 receptor alpha antagonists
TargetsInterleukin 11 receptor alpha
Therapy Area/IndicationsEndocrine System DiseasesExophthalmosGraves Ophthalmopathy +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaUnited Kingdom +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCsl Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFujifilm Diosynth Biotechnologies Denmark ApsLassen Therapeutics IncLassen Therapeutics
Inactive CompaniesN/A
Active IndicationsExophthalmosGraves OphthalmopathyPulmonary Fibrosis
Inactive IndicationsEndocrine System DiseasesEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A